12:00 AM
Dec 23, 2013
 |  BC Week In Review  |  Company News  |  Other News

Actelion, Asahi Kasei Pharma cardiovascular news

The California Court of Appeal for the first appellate district affirmed a November 2011 amended final judgment in the Superior Court of California in the County of San Mateo awarding Asahi $407.3 million related to Actelion's termination of a 2006 deal for cardiovascular product fasudil. Actelion said it and its external advisors believe...

Read the full 245 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >